We observed a similar trend like colorectal cancer (CRC), in which an Indian cohort detected to have only 20.5% KRAS mutated patients, compared to~ 40% KRAS mutants in Western counterparts (Patil et al. 2013). Here, KRAS is linked to colorectal carcinoma.